Drug Shortage Report for NALOXONE INJECTABLE
| Report ID | 177165 |
| Drug Identification Number | 02458578 |
| Brand name | NALOXONE INJECTABLE |
| Common or Proper name | NALOXONE INJECTABLE |
| Company Name | HIKMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | NALOXONE HYDROCHLORIDE |
| Strength(s) | 0.4MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 1mL |
| ATC code | V03AB |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-12-05 |
| Actual start date | |
| Estimated end date | 2022-12-31 |
| Actual end date | 2022-12-30 |
| Shortage status | Resolved |
| Updated date | 2022-12-31 |
| Company comments | This shortage pertains to non-Rx Naloxone only. NALOXONE RX INJ USP 0.4MG/ML 10X1ML AMP (DIN 02382482) remains fully available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2022-12-31 | English | Compare |
| v6 | 2022-12-30 | French | Compare |
| v5 | 2022-12-30 | English | Compare |
| v4 | 2022-12-06 | English | Compare |
| v3 | 2022-12-05 | French | Compare |
| v2 | 2022-12-05 | English | Compare |
| v1 | 2022-12-05 | English | Compare |
Showing 1 to 7 of 7